GSK PLC closed 18.99% short of its 52-week high of £17.88, which the company achieved on May 28th.

This Abrysvo or Arexvy market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the ...

The GlaxoSmithKline Capital PLC-Bond has a maturity date of 12/20/2027 and offers a coupon of 3.3750%. The payment of the coupon will take place 1,0 times per Year on the 20.12.. The ...

Shares of GSK PLC GSK rose 1.02% to £14.30 Wednesday, on what proved to be an all-around positive trading session for the ...

(Reuters) -The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

and Mr. Mackay was the Chief Financial Officer and Executive Director at GlaxoSmithKline plc, a British multinational pharmaceutical and biotechnology company, from 2019 to 2023. DOWNLOAD THE DIGITAL ...

Unilever on Tuesday announced its successful acquisition of 81.98% stake in GlaxoSmithKline (GSK) Bangladesh Ltd from Setfirst, making it the largest transaction in the history of capital market in ...

Semiconductor EDA Software Market is Segmented by Type (Electronic Circuit Design and Simulation, PCB Design, IC Design), by Application (Automotive, Industrial, Consumer Electronics, Communication, ...

Share Repurchases: $250 million at an average price of $184 per share. Icon PLC (NASDAQ:ICLR) reported better-than-expected adjusted EBITDA margin performance of 19.5% for Q1 2025, demonstrating ...